Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important curative
therapy for patients with leukemia. However, relapse remains the leading cause of death …

Abstract Background and Purpose Currently there are no widely accepted guidelines for
chimerism analysis testing in hematopoietic cell transplantation (HCT) patients. The …

This review highlights literature pertinent to chimerism analysis in the context of
hematopoietic cell transplantation (HCT). We also conducted a survey of testing practices of …

The rate and extent of natural killer (NK)–cell education after hematopoietic cell
transplantation correlates with leukemia control. To study the effect of donor and host HLA …

Background Adoptive NK cell infusion is a promising immunotherapy for acute myeloid
leukemia (AML) patients. The aim of this study was to test the activity of clinical‐grade …

Although allogeneic hematopoietic cell transplantation (allo-HCT) is currently the standard
curative treatment of acute leukemia, relapse remains unacceptably high. Measurable …

Although quantitative PCR (qPCR) has been explored for chimerism monitoring after
allogeneic stem cell transplantation (SCT), evidence regarding its clinical utility compared …

Primarily due to recent advances of detection techniques, microchimerism (the proportion of
minor variant population is below 1%) has recently gained increasing attention in the field of …

Although generally not applied as first-line treatment of multiple myeloma, allogeneic
hematopoietic cell transplantation (allo-SCT) can still be chosen as ultimate escalation …

Increasing mixed chimerism (reemerging recipient cells) after allogeneic hematopoietic cell
transplant (allo-HCT) can indicate relapse, the leading factor determining mortality in blood …